Northwestern Mutual Wealth Management CO Aurinia Pharmaceuticals Inc. Transaction History

Northwestern Mutual Wealth Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $2,905 - $4,588	374 New	374 $2,000
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $14,850 - $28,175	2,500 New	2,500 $27,000
Q2 2021 Aug 13, 2021	SELL	$10.0 - $14.52 $4,000 - $5,808	-400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $4,920 - $7,492	400 New	400 $5,000
Q3 2019 Nov 12, 2019	SELL	$5.34 - $6.59 $10,413 - $12,850	-1,950 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$6.05 - $6.75 $11,797 - $13,162	1,950 New	1,950 $13,000

209

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.16B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.